Resection of carotid body tumors reduces arterial blood pressure. An underestimated neuroendocrine syndrome

International Journal of Surgery

Volumn 12, Issue , 2014, Pages S63-S67

  de Franciscis, Stefano ^a   Grande, Raffaele ^a   Butrico, Lucia ^a   Buffone, Gianluca ^a   Gallelli, Luca ^a   Scarcello, Edoardo ^b   Caliò, Francesco Giuseppe ^c   De Vito, Domenico ^f   Compagna, Rita ^a,f   Amato, Maurizio ^f   Fugetto, Francesco ^d   Gasbarro, Vincenzo ^a,e   Amato, Bruno ^a,f   Serra, Raffaele ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Annunziata Hospital   (Italy)

^c S ANNA HOSPITAL   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e UNIVERSITY OF FERRARA   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Arterial blood pressure; Carotid body tumor; Neuroendocrine syndrome metalloproteinases; Surgery

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; NEUTROPHIL COLLAGENASE; STROMELYSIN; MATRIX METALLOPROTEINASE; TUMOR MARKER;

ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CANCER DIAGNOSIS; CANCER SURGERY; CAROTID BODY TUMOR; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; NEUROENDOCRINE DISEASE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TUMOR BIOPSY; WESTERN BLOTTING; ADULT; AGED; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; HYPERTENSION; METABOLISM; MIDDLE AGED; SYNDROME; TREATMENT OUTCOME;

ADULT; AGED; BLOTTING, WESTERN; CAROTID BODY TUMOR; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; SYNDROME; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84909987599     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2014.05.052     Document Type: Article

References (50)

1. K.E. Joynt, J.J. Moslehi, K.L. Baughman, Paragangliomas: etiology, presentation, and management, Cardiol. Rev. 17 (4) (2009) 159-164.
2. B. Amato, T. Bianco, R. Compagna, M. Siano, G. Esposito, G. Buffone, R. Serra, S. de Franciscis, Surgical resection of carotid body paragangliomas: 10 years of experience, Am. J. Surg. 207 (2) (2014) 293-298.
3. D. Erickson, Y.C. Kudva, M.J. Ebersold, G.B. Thompson, C.S. Grant, J.A. Van Heerden, W.F. Young Jr., Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients, J. Clin. Endocrinol. Metab. 86 (11) (2001) 5210-5216.
4. O. Gimm, C. DeMicco, A. Perren, F. Giammarile, M.K. Walz, L. Brunaud, Malignant pheochromocytomas and paragangliomas: a diagnostic challenge, Langenbecks Arch. Surg. 397 (2) (2012) 155-177.
5. F. Arslan, S. Yilmaz, F. Özer, C. Andiç, T. Canpolat, H. Yavuz, I. Yi{dotless}lmaz, L.N. Özlüoğlu, Surgical treatment of carotid body tumors, Kulak Burun Bogaz Ihtis. Derg. 23 (6) (2013) 336-340.
6. M.R. Tinkham, Care of the patient undergoing surgical excision of a carotid body chemodectoma, AORN J. 91 (1) (2010) 117-128. Quiz 129-131.
7. G. Zeng, H. Feng, J. Zhao, Y. Ma, B. Huang, Y. Yang, Clinical characteristics and strategy for treatment of functional carotid body tumours, Int. J. Oral Maxillofac. Surg. 42 (4) (2013) 436-439.
8. Grotemeyer, S.M. Loghmanieh, S. Pourhassan, T.A. Sagban, F. Iskandar, P. Reinecke, W. Sandmann, Dignity of carotid body tumors. Review of the literature and clinical experiences, Chirurg 80 (9) (2009) 854-863.
9. F.H.1 van Nederveen, J. Gaal, J. Favier, E. Korpershoek, R.A. Oldenburg, E.M. de Bruyn, H.F. Sleddens, P. Derkx, J. Riviere, H. Dannenberg, B.J. Petri, P. Komminoth, K. Pacak, W.C. Hop, P.J. Pollard, M. Mannelli, J.P. Bayley, A. Perren, S. Niemann, A.A. Verhofstad, A.P. de Bruïne, E.R. Maher, F. Tissier, T. Meatchi, C. Badoual, J. Bertherat, L. Amar, D. Alataki, E. Van Marck, F. Ferrau, J. François, W.W. de Herder, M.P. Peeters, A. van Linge, J.W. Lenders, A.P. Gimenez-Roqueplo, R.R. de Krijger, W.N. Dinjens, An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis, Lancet Oncol. 10 (8) (2009) 764-771.
10. K.F.1 Andersen, R. Altaf, A. Krarup-Hansen, B. Kromann-Andersen, T. Horn, N.J. Christensen, H.W. Hendel, Malignant pheochromocytomas and paragangliomas - the importance of a multidisciplinary approach, Cancer Treat. Rev. 37 (2) (2011) 111-119.
11. V.L. Martucci, K. Pacak, Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment, Curr. Probl. Cancer 38 (1) (2014) 7-41.
12. S.H. Golden, K.A. Robinson, I. Saldanha, B. Anton, P.W. Ladenson, Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review, J. Clin. Endocrinol. Metab. 94 (6) (2009) 1853-1878.
13. J.W. Lenders, G. Eisenhofer, M. Mannelli, K. Pacak. Phaeochromocytoma, Lancet 366 (9486) (2005) 665-675.
14. C. Jiménez, G. Cote, A. Arnold, R.F. Gagel, Review: should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? J. Clin. Endocrinol. Metab. 91 (8) (2006) 2851-2858.
15. P. Zaupa, M.E. Höllwarth, Carotid body paraganglioma: rare tumor in a 15-year-old adolescent boy, J. Pediatr. Surg. 42 (4) (2007) E13-E17.
16. M.S. Sajid, G. Hamilton, D.M. Baker, Joint Vascular Research Group, A multicenter review of carotid body tumour management, Eur. J. Vasc. Endovasc. Surg. 34 (2) (2007) 127-130.
17. L.T. van Hulsteijn, N. van Duinen, M.K. Ninaber, J.A. Romijn, J.G. van Dijk, K.W. van Kralingen, B. Havekes, L. Smid, G.J. Lammers, J.C. Jansen, J.W. Smit, R.D. Thijs, E.P. Corssmit, Carotid body tumors are not associated with an increased risk for sleep-disordered breathing, Sleep. Breath. 18 (1) (2014) 103-109.
18. D. Grotemeyer, S.M. Loghmanieh, S. Pourhassan, T.A. Sagban, F. Iskandar, P. Reinecke, W. Sandmann, Dignity of carotid body tumors. Review of the literature and clinical experiences, Chirurg 80 (9) (2009) 854-863.
19. I. Sen, E. Stephen, K. Malepathi, S. Agarwal, N.K. Shyamkumar, S. Mammen, Neurological complications in carotid body tumors: a 6-year single-center experience, J. Vasc. Surg. 57 (2 Suppl.) (2013) 64S-68S.
20. T. Klein, R. Bischoff, Physiology and pathophysiology of matrix metalloproteases, Amino Acids 41 (2) (2011) 271-290.
21. K. Kessenbrock, V. Plaks, Z. Werb, Matrix metalloproteinases: regulators of the tumor microenvironment, Cell 141 (1) (2010) 52-67.
22. R. Serra, R. Grande, G. Buffone, E. Scarcello, F. Tripodi, P. Rende, L. Gallelli, S. de Franciscis, Effects of glucocorticoids and TNF-alfa inhibitors on both clinical and molecular parameters in patients with Takayasu Arteritis, J. Pharmacol. Pharmacother. ISSN: 0976-500X (2014) (in press).
23. R. Serra, G. Buffone, G. Costanzo, R. Montemurro, E. Scarcello, D.M. Stillitano, R. Damiano, S. de Franciscis, Altered metalloproteinase-9 expression as the least common denominator between varicocele, inguinal hernia and chronic venous disorders, Ann. Vasc. Surg. 28 (3) (2014) 705-709.
24. B. Amato, G. Coretti, R. Compagna, M. Amato, G. Buffone, D. Gigliotti, R. Grande, R. Serra, S. De Franciscis, Role of matrix metalloproteinases in nonhealing venous ulcers, Int. Wound J. (2013), http://dx.doi.org/10.1111/ Iwj.12181 (Epub ahead of print).
25. R. Serra, G. Buffone, D. Falcone, V. Molinari, M. Scaramuzzino, L. Gallelli, S. De Franciscis, Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin, Wound Repair Regen. 21 (3) (2013) 395-401.
26. R. Serra, R. Grande, L. Butrico, G. Buffone, Fg Calió A. Squillace, B.A. Rizzo,M. Massara, F. Spinelli, A.G. Ferrarese, G. De Caridi, L. Gallelli, S. De Franciscis.
27. R. Serra, R. Grande, L. Butrico, G. Buffone, Fg Caliò, A. Squillace, B.A. Rizzo, M. Massara, F. Spinelli, A.G. Ferrarese, G. De Caridi, L. Gallelli, S. De Franciscis, Effects of a new nutraceutical substance on clinical and molecular parameters in patients with chronic venous ulceration, Int. Wound J. (2014), http:// dx.doi.org/10.1111/Iwj.12240 (Epub ahead Of print).
28. M.T. Busceti, R. Grande, B. Amato, V. Gasbarro, G. Buffone, M. Amato, L. Gallelli, R. Serra, S. de Franciscis. Pulmonary embolism, metalloproteinases and neutrophil gelatinase associated lipocalin, Acta Phlebol. 14 (2013) 115-121.
29. S. de Franciscis, P. Mastroroberto, L. Gallelli, G. Buffone, R. Montemurro, R. Serra, Increased plasma levels of metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in a rare case of multiple artery aneurysm, Ann. Vasc. Surg. 27 (8) (2013) 1185.e5-1185.e7.
30. S. de Franciscis, L. Gallelli, L. Battaglia, V. Molinari, R. Montemurro, D.M. Stillitano, G. Buffone, R. Serra, Cilostazol prevents foot ulcers in diabetic patients with peripheral vascular disease, Int. Wound J. (2013), http:// dx.doi.org/10.1111/iwj.12085 (Epub ahead of print).
31. R. Serra, L. Gallelli, G. Buffone, V. Molinari, D.M. Stillitano, C. Palmieri, S. de Franciscis. Doxycycline speeds up healing of chronic venous ulcers, Int. Wound J. (2013), http://dx.doi.org/10.1111/iwj.12077 (Epub ahead of print).
32. R. Serra, L. Gallelli, A. Conti, G. De Caridi, M. Massara, F. Spinelli, G. Buffone, F.G. Caliò, B. Amato, S. Ceglia, G. Spaziano, L. Scaramuzzino, A. Ferrarese, R. Grande, S. de Franciscis. The effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbs, Drug Des. Devel Ther. 8 (2014) 519-527.
33. R. Serra, R. Grande, G. Buffone, V. Molinari, P. Perri, A. Perri, B. Amato, M. Colosimo, S. de Franciscis. Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines, Int. Wound J. (2014), http://dx.doi.org/10.1111/iwj.12225 (Epub ahead of print).
34. R. Serra, R. Grande, L. Gallelli, P. Rende, E. Scarcello, G. Buffone, F.G. Caliò, V. Gasbarro, B. Amato, S. de Franciscis. Carotid body paragangliomas and matrix metalloproteinases, Ann. Vasc. Surg. (2014), http://dx.doi.org/10.1016/ j.avsg.2014.03.022 (in press).
35. M.M. Castro, E. Rizzi, L. Figueiredo-Lopes, K. Fernandes, L.M. Bendhack, D.L. Pitol, R.F. Gerlach, J.E. Tanus-Santos, Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats, Atherosclerosis 198 (2) (2008) 320-331.
36. M.M. Castro, E. Rizzi, C.M. Prado, M.A. Rossi, J.E. Tanus-Santos, R.F. Gerlach, Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling, Matrix Biol. 29 (3) (2010) 194-201.
37. R. Huang, L. Deng, A. Shen, J. Liu, H. Ren, D.L. Xu, Associations of MMP1, 3, 9 and TIMP3 genes polymorphism with isolated systolic hypertension in Chinese Han population, Int. J. Med. Sci. 10 (7) (2013) 840-847.
38. W. Su, F. Gao, J. Lu, W. Wu, G. Zhou, S. Lu, Levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 mRNAs in patients with primary hypertension or hypertension-induced atherosclerosis, J. Int. Med. Res. 40 (3) (2012) 986-994.
39. T.M. Tran, N.M. Giang, Changes in blood pressure classification, blood pressure goals and pharmacological treatment of essential hypertension in medical guidelines from 2003 to 2013, Int. J. Cardiol. 2 (2014) 1-10.
40. 2+ concentration in rat carotid body glomus cells, Respir. Physiol. Neurobiol. 195C (2014) 19-26.
41. D.E. Benn, A.P. Gimenez-Roqueplo, J.R. Reilly, J. Bertherat, J. Burgess, K. Byth, M. Croxson, P.L. Dahia, M. Elston, O. Gimm, D. Henley, P. Herman, V. Murday, P. Niccoli-Sire, J.L. Pasieka, V. Rohmer, K. Tucker, X. Jeunemaitre, D.J. Marsh, P.F. Plouin, B.G. Robinson, Clinical presentation and penetrance of pheochromocytoma/ paraganglioma syndromes, J. Clin. Endocrinol. Metab. 91 (3) (2006) 827-836.
42. F. Bougrine, F. Maamouri, R. Doghri, I. Msakni, N. Sabbegh Znaidi, O. Chouchane, A. Bouzaine, An exceptional carotid tumor, J. Mal. Vasc. 33 (4-5) (2008) 214-217.
43. W.R. Shamblin, W.H. ReMine, S.G. Sheps, E.G. Harrison Jr., Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases, Am. J. Surg. 122 (6) (1971) 732-739.
44. M.D. Williams, M.J. Phillips, W.R. Nelson, W.G. Rainer, Carotid body tumor, Arch. Surg. 127 (8) (1992) 963-967 discussion 967-8.
45. B.K. Mathew, T. Bandgar, P.S. Menon, N.S. Shah, Carotid body tumours: three case reports, Singap. Med. J. 50 (2) (2009) e58-e60.
46. H. Heckl, V. Barth, Carotid body tumor associated with refractory hypertension, Munch Med. Wochenschr. 111 (30) (1969) 1566-1568.
47. J. Marek, K. Horký, J. Kopecká, Functionally active tumor of the carotid body, Cesk Patol. 12 (4) (1976) 197-202.
48. M. Nakamizo, S. Kamata, M. Uchida, M. Yokota, Y. Satoh, H. Aramaki, Case report of catecholamine-secreting carotid body tumor, Nihon Jibiinkoka Gakkai Kaiho 92 (2) (1989) 246-252.
49. G. Balasubramanian, V. Nellaiappan, Functional paraganglioma, BMJ Case Rep. 2014 (2014).
50. B.A. Erdogan, F. Bora, G. Altin, M. Paksoy, Our experience with carotid body paragangliomas, Prague Med. Rep. 113 (4) (2012) 262-270.